Golden Biotechnology Valuation
| 4132 Stock | TWD 16.45 0.40 2.37% |
At this time, the firm appears to be fairly valued. Golden Biotechnology retains a regular Real Value of NT$16.71 per share. The prevalent price of the firm is NT$16.45. Our model calculates the value of Golden Biotechnology from evaluating the firm fundamentals such as Shares Outstanding of 115.76 M, return on asset of -17.85, and Return On Equity of -36.95 as well as inspecting its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Golden Biotechnology's price fluctuation is not too volatile at this time. Calculation of the real value of Golden Biotechnology is based on 3 months time horizon. Increasing Golden Biotechnology's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Golden stock is determined by what a typical buyer is willing to pay for full or partial control of Golden Biotechnology. Since Golden Biotechnology is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Golden Stock. However, Golden Biotechnology's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 16.45 | Real 16.71 | Hype 16.45 | Naive 14.59 |
The intrinsic value of Golden Biotechnology's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Golden Biotechnology's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Golden Biotechnology helps investors to forecast how Golden stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Golden Biotechnology more accurately as focusing exclusively on Golden Biotechnology's fundamentals will not take into account other important factors: Golden Biotechnology Total Value Analysis
Golden Biotechnology is presently anticipated to have takeover price of 5.17 B with market capitalization of 5.15 B, debt of 227.3 M, and cash on hands of 152.56 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Golden Biotechnology fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
5.17 B | 5.15 B | 227.3 M | 152.56 M |
Golden Biotechnology Investor Information
The company recorded a loss per share of 2.97. Golden Biotechnology had not issued any dividends in recent years. Based on the key measurements obtained from Golden Biotechnology's financial statements, Golden Biotechnology is not in a good financial situation at the moment. It has a very high risk of going through financial straits in March.Golden Biotechnology Asset Utilization
One of the ways to look at asset utilization of Golden is to check how much profit was generated for every dollar of assets it reports. Golden Biotechnology retains a negative application of resources of -17.85 (percent), losing NT$0.18 for each dollar of resources held by the firm. Inadequate asset utilization attests that the company is being less effective with each dollar of resources it retains. Simply put, asset utilization of Golden Biotechnology shows how discouraging it operates for each dollar spent on its resources.Golden Biotechnology Profitability Analysis
The company reported the revenue of 78.35 M. Net Loss for the year was (336.49 M) with profit before overhead, payroll, taxes, and interest of 51.31 M.About Golden Biotechnology Valuation
Our relative valuation model uses a comparative analysis of Golden Biotechnology. We calculate exposure to Golden Biotechnology's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Golden Biotechnology's related companies.Golden Biotechnology Corporation operates as a drug discovery and healthy food supplement manufacturing company. Golden Biotechnology Corporation was founded in 2002 and is based in New Taipei City, Taiwan. GOLDEN BIOTECHNOLOGY operates under Drug Manufacturers - Specialty Generic classification in Taiwan and is traded on Taiwan OTC Exchange. It employs 135 people.
8 Steps to conduct Golden Biotechnology's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Golden Biotechnology's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Golden Biotechnology's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Golden Biotechnology's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Golden Biotechnology's revenue streams: Identify Golden Biotechnology's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Golden Biotechnology's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Golden Biotechnology's growth potential: Evaluate Golden Biotechnology's management, business model, and growth potential.
- Determine Golden Biotechnology's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Golden Biotechnology's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Golden Stock Analysis
When running Golden Biotechnology's price analysis, check to measure Golden Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Golden Biotechnology is operating at the current time. Most of Golden Biotechnology's value examination focuses on studying past and present price action to predict the probability of Golden Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Golden Biotechnology's price. Additionally, you may evaluate how the addition of Golden Biotechnology to your portfolios can decrease your overall portfolio volatility.